Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Global Value Dossier

- PMLiVE

Bayer’s Diane 35 faces ban in France

Follows investigation into blood clot-related deaths

- PMLiVE

FDA advisors back Boehringer’s COPD drug olodaterol

Committee votes 15 to 1 in favour despite cancer concerns

Roche - Basel

Roche delivers solid sales gain in 2012

New cancer products, such as Perjeta and Zelboraf, help growth

- PMLiVE

Anker Lundemose appointed CEO of Bionor Pharma

Will lead efforts to develop and commercialise HIV vaccines

- PMLiVE

Healthcare UK launches to sell NHS expertise abroad

Will provide services to international private and public healthcare providers

- PMLiVE

How close are we to a tricorder?

The intersection of smartphones and medical technology is increasing the pace of change

Sanofi reception

US approval for Sanofi’s Kynamro in genetic cholesterol disorder

Comes one month after drug was turned down in Europe due to safety concerns

Majority of US adults track their health data

But just one in five uses technology to do so

- PMLiVE

New products help Lilly achieve flat Q4 sales

Effient and Alimta counter patent expiry to Zyprexa

- PMLiVE

Pfizer revenues decline in Q4 but profits surge

Lipitor patent loss continues to hit sales

- PMLiVE

Europe builds links with African researchers

EDCTP and EFPIA launch fellowship scheme for Africans to spend time at European pharma firms

Questcor appoints SVP corporate strategic development

Michael Aldridge joins from Australian early development company Xenome

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links